![]() | You can helpexpand this article with text translated fromthe corresponding article in German.Click [show] for important translation instructions.
|
![]() | |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral,IM,IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Eliminationhalf-life | 3 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.056.082![]() |
Chemical and physical data | |
Formula | C16H21N5O2 |
Molar mass | 315.377 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Alizapride (Litican,Plitican,Superan,Vergentan) is adopamine antagonist withprokinetic andantiemetic effects used in the treatment ofnausea andvomiting, includingpostoperative nausea and vomiting. It is structurally related tometoclopramide and otherbenzamides.[1]
![]() | Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |